Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03203369
Title Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN (ABC123)
Acronym ABC123
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field